Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.

Daisuke TakahariKeisho ChinNaoki IshizukaAtsuo TakashimaKeiko MinashiShigenori KadowakiTomohiro NishinaTakako Eguchi NakajimaKenji AmagaiNozomu MachidaMasahiro GotoKeisei TakuTakeru WakatsukiHirokazu ShojiShuichi HironakaNarikazu BokuKensei Yamaguchi

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)

UMIN000017602.

Keyphrases

phase ii study
locally advanced
neoadjuvant chemotherapy
rectal cancer
squamous cell carcinoma
radiation therapy
epidermal growth factor receptor
open label
metastatic breast cancer
cross sectional
double blind
placebo controlled
randomized controlled trial
lymph node
tyrosine kinase
study protocol